Journal of the American Chemical Society
Article
884(15), 1046(13), 1108(11), 1261(4), 1308(10), 1382(12), 1444(5),
1588(2), 2866(7), 2917(1). HRMS: C34H47N3 calcd (found) 497.3770
(497.3771). Anal. Calcd for C34H47N3: C 82.04, H 9.52, N 8.44.
Found: C 81.93, H 9.47, N 8.46.
35%. Mp: 142−146 °C. X-ray quality colorless crystals were obtained
1
after three days from a concentrated hexanes solution at −20 °C. H
NMR (−30 °C):50 δ 7.38 (t, 1H, aryl, 3JH−H = 7.6), 7.30 (d, 1H, aryl,
3JH−H = 7.6), 7.26 (d, 1H, aryl, 3JH−H = 7.6), 6.76 (s, 1H, aryl), 6.58 (s,
1H, aryl), 6.54 (s, 1H, aryl), 6.25 (s, 1H, aryl), 3.81 (sept, 1H,
1PCl. To a toluene solution (30 mL) of 1 (2.64 g, 6.39 mmol) were
added PCl3 (0.72 mL, 8.31 mmol) and NEt3 (2.30 mL, 16.5 mmol)
sequentially. The cloudy reaction mixture was stirred at rt for 2.5 h.
The reaction mixture was cannula transferred to a Schlenk filter frit,
and the yellow filtrate was dried in vacuo to give a yellow powder. The
powder was dissolved in CH2Cl2 (2 mL), and CH3CN (5 mL) was
added with vigorous stirring to precipitate a white powder. The
suspension was centrifuged and the yellow solution decanted. This
process was repeated, and the decanted solutions were combined and
placed in the freezer (−30 °C) for 30 min, during which more white
powder precipitated. The solution was decanted, and the powder was
dissolved in CH2Cl2 (2 mL) and added to those collected by cen-
trifugation. The volatiles were removed in vacuo to give 1PCl as a
white powder (2.11 g, 4.42 mmol). Yield: 69%. Mp: 143−146 °C.
Single crystals suitable for X-ray diffraction experiments were grown by
diffusion of CH3CN into a concentrated CH2Cl2 solution of the bulk
3
3
CH(CH3)2, JH−H = 6.4), 3.42 (sept, 1H, CH(CH3)2, JH−H = 6.8),
2.49 (s, 3H, CH3), 2.27 (s, 3H, CH3), 2.21 (s, 3H, CH3), 2.15 (s, 3H,
CH3), 2.02 (s, 3H, CH3), 1.90 (s, 3H, CH3), 1.38 (m, 9H, CH(CH3)2,
50
1.32 (d, 3H, CH(CH3)2, JH−H = 6.8). 13C{1H} NMR (−30 °C):
δ
3
150.2, 148.1, 145.5 (d, 2J13C−P = 5.9), 138.4, 137.6, 137.1, 134.6, 131.4,
2
130.2, 129.2, 129.1 (d, J13C−P = 2.8), 128.95, 128.9, 128.6, 128.1,
127.8, 127.3, 124.4, 123.9, 29.5 (d, J13C−P = 4.2), 28.8, 25.8, 25.5 (d,
J13C−P = 4.8), 24.6, 24.3, 21.0, 20.7, 20.1 (d, J13C−P = 9.9), 19.8, 19.1,
18.3. 31P{1H} NMR: δ 180.5 (s). FT-IR (cm−1 (ranked intensity)):
462(4), 561(13), 681(10), 714(15), 767(9), 803(5), 846(12), 985(6),
1227(11), 1266(2), 1317(8), 1466(7), 1608(14), 1698(1), 2963(3). FT-
Raman (cm−1 (ranked intensity)): 97(15), 143(7), 226(6), 461(8),
575(2), 1009(14), 1316(10), 1358(5), 1455(9), 1590(12), 1609(4),
1701(3), 2863(11), 2917(1), 2964(13).
4PCl. This compound was synthesized from 4 (0.75 g, 1.51 mmol),
PCl3 (0.17 mL, 1.96 mmol), and NEt3 (0.55 mL, 3.92 mmol). Yield:
61%. Mp: 138−141 °C. X-ray quality colorless crystals were obtained
after two weeks from a concentrated CH2Cl2/Et2O solution
50
1
material at −30 °C for 4 weeks. H NMR (−30 °C): δ 6.87 (s, 2H,
aryl), 6.77 (s, 2H, aryl), 6.57 (s, 1H, aryl), 6.24 (s, 1H, aryl), 2.49 (s,
6H, CH3), 2.41 (s, 6H, CH3), 2.26 (s, 3H, CH3), 2.22 (s, 6H, CH3),
2.02 (s, 3H, CH3), 1.88 (s, 3H, CH3). 13C{1H} NMR (−30 °C):50
δ
50
1
3
at −20 °C. H NMR (−30 °C): δ 7.43 (t, 1H, aryl, JH−H = 7.6), 7.34
(d, 1H, aryl, 3JH−H = 7.6), 7.30 (d, 1H, aryl, 3JH−H = 7.6), 6.92 (d, 1H,
2
144.8 (d, J13C−P = 6.0), 138.5, 138.3, 137.8, 135.9 (br), 131.3, 130.0,
2
3
3
3
129.2, 128.9 (d, J13C−P = 5.3), 128.0, 127.7 (d, J13C−P = 3.7), 127.3,
127.2, 21.1, 20.7, 20.3, 19.9 (br), 19.1, 18.4. 31P{1H} NMR: δ 181.1
(s). FT-IR (cm−1 (ranked intensity)): 448(6), 562(8), 682(10), 714(15),
756(11), 849(4), 948(14), 986(3), 1173(13), 1263(2), 1312(9), 1480(5),
1608(12), 1720(1), 2915(7). FT-Raman (cm−1 (ranked intensity)):
120(9), 193(11), 225(14), 253(7), 391(15), 448(8), 574(1), 1008(12),
1347(5), 1381(6), 1485(10), 1610(3), 1716(4), 2916(2), 3018(13). Anal.
Calcd for C28H33N3PCl: C 70.35, H 6.96, N 8.79. Found: C 69.32, H
7.18, N 8.65.
aryl, JH−H = 7.2), 6.78 (s, 1H, aryl), 6.75 (t, 1H, aryl, JH−H = 7.6),
6.53 (d, 1H, aryl), 6.51 (s, 1H, aryl), 3.80 (sept, 1H, CH(CH3)2, 3JH−H
=
=
3
6.8), 3.39 (m, 2H, CH(CH3)2), 2.94 (sept, 1H, CH(CH3)2, JH−H
6.4), 2.47 (s, 3H, CH3), 2.15 (s, 3H, CH3), 2.13 (s, 3H, CH3), 1.41
3
(m, 9H, CH(CH3)2), 1.35 (d, 3H, CH(CH3)2, JH−H = 6.4), 1.32 (d,
3
3H, CH(CH3)2, JH−H = 6.8), 0.95 (m, 6H, CH(CH3)2), 0.83 (d, 3H,
50
3
CH(CH3)2, JH−H = 6.4). 13C{1H} NMR (−30 °C): δ 150.7, 148.4,
142.7 (d, 2J13C−P = 5.6), 139.7, 138.6, 138.3, 137.1, 137.0, 134.4, 130.3,
129.5 (d, J13C−P = 4.0), 129.0, 128.95, 128.9, 124.2, 123.6, 122.7,
2
General Synthesis for Halophosphine. To a toluene solution (20 mL)
of guanidine (1−5) were added 1.3 and 2.6 equiv of PX3 (X = Cl, Br) and
NEt3, respectively, in a sequential fashion. The reaction mixture was
left to stir at rt overnight, during which time the solution became
cloudy. Volatiles were removed in vacuo giving an off-white solid, which
was resuspended in THF. The white solid was removed by centrifugation,
and the liquid was concentrated in vacuo to give an off-white solid. The
product was washed with CH3CN (2 × 4 mL), decanting the colored
solution each time. The product was dried in vacuo to give a white solid.
Specific Procedures for Halophosphines. 2PCl. This compound
was prepared from 2 (0.75 g, 1.39 mmol), PCl3 (0.16 mL,
1.83 mmol), and NEt3 (0.50 mL, 3.59 mmol). Yield: 72%. Mp:
127−130 °C. X-ray quality colorless crystals were obtained
from a concentrated CH2Cl2 solution after four weeks at −20 °C.
121.6, 120.6, 29.5 (d, J13C−P = 2.9), 29.0, 28.9, 28.4, 26.5 (d, J13C−P
=
8.0), 26.4, 25.2, 24.9, 24.1, 23.9, 21.2, 21.0, 20.5, 19.8 (d, J13C−P = 10.9),
19.2. 31P{1H} NMR: δ 178.6 (s). FT-IR (cm−1 (ranked intensity)):
432(11), 461(9), 558(15), 675(12), 754(5), 782(7), 883(14), 986(4),
1268(3), 1317(8), 1362(13), 1465(6), 1587(10), 1705(1), 2965(2). FT-
Raman (cm−1 (ranked intensity)): 109(9), 200(14), 462(8), 578(5),
625(11), 887(7), 1011(13), 1259(10), 1319(12), 1360(4), 1448(6),
1590(2), 1708(3), 2925(1), 3065(15). Anal. Calcd for C34H45N3PCl: C
72.64, H 8.07, N 7.47. Found: C 71.97, H 8.06, N 7.37.
5PCl. This compound was synthesized from 5 (0.55 g, 1.80 mmol),
PCl3 (0.20 mL, 2.34 mmol), and NEt3 (0.65 mL, 4.68 mmol). Yield:
50
1
31%. Mp: 75−78 °C. H NMR (−30 °C): δ 3.53−3.35 (m, 3H,
CH), 2.10−2.01 (m, 4H, CH2), 1.82−1.14 (m, 26H, CH2). 13C{1H}
NMR (−30 °C):50 δ 145.6, 55.9, 54.5, 51.4, 35.5, 35.3, 33.6, 33.5, 33.4,
32.1, 31.8, 25.61, 25.56, 25.4, 25.2, 25.1, 25.0. 31P{1H} NMR: δ 181.5
(s). FT-IR (cm−1 (ranked intensity)): 433(7), 655(3), 699(8),
725(14), 839(10), 890(9), 988(4), 1109(13), 1148(12), 1215(5),
1298(11), 1361(15), 1449(6), 1704(2), 2930(1). FT-Raman (cm−1
(ranked intensity)): 85(8), 143(14), 216(6), 430(10), 659(13),
728(12), 811(7), 1027(9), 1253(11), 1347(15), 1444(4), 1702(3),
2854(2), 2887(5), 2938(1). Anal. Calcd for C19H33N3PCl: C 61.69, H
8.99, N 11.36. Found: C 61.35, H 9.26, N 11.17.
50
3
1H NMR (−30 °C): δ 7.30 (t, 2H, aryl, JH−H = 7.6), 7.22
(d, 2H, aryl, 3JH−H = 7.6), 7.13 (m, 2H, aryl), 7.00 (d, 1H, aryl,
3
3JH−H = 7.6), 6.81 (t, 1H, aryl, JH−H = 7.6), 6.61 (d, 1H, aryl,
3JH−H = 7.6), 3.42 (m, 4H, CH(CH3)2), 3.31 (br sept, 1H,
CH(CH3)2), 2.47 (br sept, 1H, CH(CH3)2), 1.41 (d, 6H,
CH(CH3)2, 3JH−H = 6.4), 1.32 (d, 6H, CH(CH3)2, 3JH−H = 6.8),
3
1.26 (d, 6H, CH(CH3)2, JH−H = 6.8), 1.18 (m, 9H,
3
CH(CH3)2), 0.86 (d, 6H, CH(CH3)2, JH−H = 6.4), 0.56 (d,
δ
50
3
6H, CH(CH3)2, JH−H = 6.0). 13C{1H} NMR (−30 °C):
1PBr. This compound was synthesized from 1 (0.93 g, 2.24 mmol),
PBr3 (0.27 mL, 2.92 mmol), and NEt3 (0.81 mL, 5.81 mmol). Yield:
70%. Mp: 117−123 °C. Single crystals suitable for X-ray diffraction
experiments were grown by diffusion of CH3CN into a concentrated
149.5, 147.5, 141.3 (d, 2J13C−P = 5.6), 140.0, 138.5, 137.4, 130.6
(d, 2J13C−P = 4.8), 128.8, 124.1, 124.0, 123.4, 123.0, 121.2, 30.1,
30.0, 28.9, 28.2, 27.4, 27.3, 23.6, 23.3, 22.9, 22.6, 22.4. P{1H}
31
1
NMR: δ 179.9 (s). FT-IR (cm−1 (ranked intensity)): 527(15),
674(11), 752(8), 786(4), 984(3), 1121(10), 1219(7), 1260(5),
1323(9), 1363(14), 1386(12), 1438(6), 1588(13), 1717(1),
2965(2). FT-Raman (cm−1 (ranked intensity)): 137(6), 279(9),
451(13), 887(5), 1048(15), 1104(12), 1252(14), 1299(10),
1353(8), 1443(4), 1589(1), 1718(3), 2867(7), 2909(2), 3062(11).
Anal. Calcd for C37H51N3PCl: C 73.55, H 8.51, N 6.95. Found: C
72.69, H 8.66, N 6.90.
CH2Cl2 solution of the bulk material at −30 °C for 3 days. H NMR
(−30 °C):50 δ 6.88 (s, 2H, aryl), 6.79 (br s, 2H, aryl), 6.61 (s, 1H,
aryl), 6.26 (s, 1H, aryl), 2.49 (s, 6H, CH3), 2.47 (br s, 6H, CH3), 2.29
(s, 3H, CH3), 2.24 (s, 6H, CH3), 2.04 (s, 3H, CH3), 1.89 (s, 3H, CH3).
50
2
13C{1H} NMR (−30 °C): δ 144.1 (d, J13C−P = 5.13 Hz), 138.2,
137.8, 135.6, 131.4, 129.8, 129.4, 129.0, 127.9, 127.8, 127.3, 21.1, 20.7,
20.3, 19.9, 19.8, 19.3, 18.3. 31P{1H} NMR: δ 200.2 (s). FT-IR (cm−1
(ranked intensity)): 414(15), 559(7), 674(11), 756(9), 803(14), 849(6),
951(12), 983(3), 1268(2), 1315(8), 1374(13), 1478(4), 1609(10),
1698(1), 2916(5). FT-Raman (cm−1 (ranked intensity)): 97(8),
3PCl. This compound was synthesized from 3 (1.10 g, 2.42 mmol),
PCl3 (0.27 mL, 3.12 mmol), and NEt3 (0.87 mL, 6.25 mmol). Yield:
5401
dx.doi.org/10.1021/ja300587z | J. Am. Chem. Soc. 2012, 134, 5398−5414